Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's Syndrome

Swedish Dental Journal

Volumn 32, Issue 2, 2008, Pages 49-56

  Jorkjend, Lars ^a   Bergenholtz, Axel ^b   Johansson, Ann Katrin ^c   Johansson, Anders ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Pilocarpine; Salivation; Sj gren's syndrome

Indexed keywords

MUSCARINIC AGENT; PILOCARPINE;

ADULT; AGED; ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; QUESTIONNAIRE; SALIVA; SALIVATION; SECRETION; SJOEGREN SYNDROME; XEROSTOMIA;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; PILOCARPINE; QUESTIONNAIRES; SALIVA; SALIVATION; SJOGREN'S SYNDROME; XEROSTOMIA;

EID: 47149096214     PISSN: 03479994     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bell M, Askari A, Bookman A, Frydrych S, Lamont J, McComb J, Muscoplat C, Slomovic A. Sjogren's syndrome: a critical review of clinical management. J Rheumatol 1999;26:2051-61.
2. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjöoegren's Syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965;44:187-231.
3. Blom M, Kopp S, Lundeberg T. Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment. Arch Otolaryngol Head Neck Surg 1999;125:561-6.
4. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994;37:869-77.
5. Fawcett JP, Tucker I, Davies NM, Ferguson M. Formulation and stability of pilocarpine oral solution. Int J Pharm Pract 1997;3:14-8.
6. Fox PC, Atkinson JC, Macyski AA et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991;151:1149-52.
7. Haga HJ, Hulten B, Bolstad Al, Ulvestad E, Jonsson R. Reliability and sensitivity of diagnostic tests for primary Sjogren's syndrome. J Rheumatol 1999;26:604-8.
8. Halse AK. Autoimmunity to the Ro/SS-A and La/SS-B antigens in Sjögren's syndrome. Thesis, University of Bergen, Norway, 1999.
9. Jonsson R, Bowman SJ, Gordon TP. Sjögrens's syndrome. In: WJ Koopman, Morland LW (Eds). Arthritis and Allied Conditions 15th ed. Philadelphia: Lippincott Williams & Wilkins. 2005:1681-1705.
10. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005;25:189-201.
11. Jonsson MV. Ectopic germinal center formation in Sjögren's syndrome. Doctoral thesis, University of Bergen, Norway, 2006.
12. Jorkjend L, Johansson A, Johansson AK, Bergenholtz A. Periodontitis, caries and salivary factors in Sjögren's syndrome patients compared to sex- and age-matched controls. Journal of Oral Rehabilitation 2003;30:369-78.
13. Jorkjend L, Johansson A, Johansson AK, Bergenholtz A. Resting- and stimulated saliva flow rate in Sjögren's syndrome patients over time - a diagnostic aid for free dental care? Acta Odontol Scand 2004;62:264-8.
14. Järvinen VK, Rytomaa II, Heinonen OP. Risk factors in dental erosion. J Dent Res 1991;70:942-7.
15. Lagerlöf F, Almqvist H, Oliveby A. Provtagningsförfarande vid bestämning av salivens sekretionshastighet. Bilaga 2. Rapport från arbetsgrupp med uppgift att förbereda landstingens övertagande av kostnadsansvaret för patienter som på grund av Sjögrens syndrom eller strålbehandling har nedsatt salivkörtelfunktion. På uppdrag från Socialdepartementet/Landstingsförbundet 1999-10-29.
16. Manthorpe R. New criteria for diagnosing Sjogren's syndrome: a step forward?-or... Scand J Rheumatol Suppl 2001:14-20: discussion 20-2.
17. Nederfors T, Holmström G, Paulsson G, Sahlberg D. The relation between xerostomia and hyposalivation in subjects with rheumatoid arthritis or fibromyalgia. Swed Dent J 2002;26:1-7.
18. Nederfors T. Xerostomia and hyposalivation. Adv Dent Res 2000;14:48-56.
19. Pedersen AM, Bardow A, Nauntofte B. Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjogren's syndrome. BMC Clin Pathol 2005;5:4.
20. Nusair S, Rubinow A. The use of oral pilocarpine in xerostomia and Sjögren's syndrome. Semin Arthritis Rheum 1999;28:360-7.
21. Papas AS, Fernandez MM, Castano RA, Gallagher SC, Trivedi M, Shrrotriya RC. Oral pilocarpine for symptomatic relief of dry mouth and dry eyes in patients with Sjögren's syndrome. Adv Exp Med Biol 1998;438:973-8.
22. Porter SR, Scully C, Hegarty AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:28-46.
23. Rhodus NL, Schuh MJ. Effects of pilocarpine on salivary flow in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1991;72:545-9.
24. Rosas J, Ena J, Capdevila L et al. Usefulness of pilocarpine in patients with primary Sjögren's syndrome. Arthritis Rheum 1995;38 (Suppl.):337
25. Rosas J, Ramos-Casals M, Ena J et al. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjogren's syndrome. Correlation with clinical, immunological and histological features. Rheumatology (Oxford) 2002;41:670-5.
26. Sjögren H. Some problems concerning keratoconjunctivitis sicca and the sicca-syndrome. Acta Ophthalmol (Copenh) 1951;29:33-47.
27. Sjögren, H.S. (1933) Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis foliformis bei Hypofunction der Tranendrusen). Acta Ophthalmol, Supplement 2, 1-151.
28. Speight PM, Kaul A, Melsom RD. Measurement of whole unstimulated salivary flow in the diagnosis of Sjogren's syndrome. Ann Rheum Dis 1992;51:499-502.
29. Vitali C, Bombardieri S, Jonsson R et al. European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
30. 92-01 Study Group. Arch Intern Med 1999;159:174-81.
31. Wang SL, Zhao ZT, Li J, Zhu XZ, Dong H, Zhang YG. Investigation of the clinical value of total saliva flow rates. Arch Oral Biol 1998;43:39-43.